来自MSN11 个月
Nirmatrelvir fails to shorten COVID-19 symptoms in latest trial
Nirmatrelvir is administered with the pharmacokinetic enhancer ritonavir to inhibit metabolism by CYP3A4." One of the most promising antiviral therapies currently in clinical trials is the ...
WebMD3 年
Nintedanib/P-gp and Selected CYP3A4 Inhibitors Interactions
This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment. The ...
WebMD3 年
Selected Sensitive CYP3A4 Substrates/Schisandra Interactions
This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment ...
The Hearty Soul on MSN8 个月
Woman Experiencing Burning Pains Turns Out To Have Medieval ‘Holy Fire' Disease
The woman was also taking ritonavir to treat HIV. This inhibited the enzyme CYP3A4, which caused serum levels of ergotamine ...
Monthly Prescribing Reference3 年
Emend Injection
Avoid concomitant moderate-to-strong CYP3A4 inhibitors (eg, azole antifungals, macrolides, nefazodone, ritonavir, nelfinavir, diltiazem) or strong CYP3A4 inducers (eg, carbamazepine, phenytoin ...